Visuocortical function in infants with a history of neonatal jaundice

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 10, 2014, Pages 6443-6449

  Hou, Chuan ^a   Norcia, Anthony M ^b   Madan, Ashima ^c   Good, William V ^a  

^a SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast sensitivity; Hyperbilirubinemia; Jaundice; Spatial frequency; Swept parameter visual evoked potentials; Vernier acuity

Indexed keywords

BILIRUBIN;

ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ETHNICITY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; MALE; NERVE FUNCTION; NEUROTOXICITY; NEWBORN; NEWBORN JAUNDICE; QUANTITATIVE ANALYSIS; SPATIAL FREQUENCY DISCRIMINATION; VISIBILITY; VISION; VISUAL CORTEX; VISUAL NERVOUS SYSTEM; VISUAL STIMULATION; VISUAL THRESHOLD; BLOOD; COMPARATIVE STUDY; FOLLOW UP; INFANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; VISUAL ACUITY;

BILIRUBIN; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; PROGNOSIS; PROSPECTIVE STUDIES; VISUAL ACUITY; VISUAL CORTEX;

EID: 84908099174     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14261     Document Type: Article

References (39)

1. Maisels MJ. What’s in a name? Physiologic and pathologic jaundice: the conundrum of defining normal bilirubin levels in the newborn. Pediatrics. 2006;118:805-807
2. Perlstein M. Neurologic sequelae of erythroblastosis fetalis. Am J Dis Child. 1950;79:605-606
3. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics. 1994;94(pt 1):558-565
4. Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354:1889-1900
5. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114: 297-316
6. Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res. 2001;50:701-705
7. Perlman M, Fainmesser F, Sohmer H, Tamari H, Wax Y, Pevsmer B. Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics. 1983;72:658-664
8. De Vries LS, Lary S, Whitelaw AG, Dubowitz LM. Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Hum Dev. 1987;15:269-277
9. Scheidt PC, Mellits ED, Hardy JB, Drage JS, Boggs TR. Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr. 1977;91:292-297
10. Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear. 1999;20:238-252
11. Vohr BR, Coll CG, Lobato D, Yunis KA, O’Dea C, Oh W. Neurodevelopmental and medical status of low-birthweight survivors of bronchopulmonary dysplasia at 10 to 12 years of age. Dev Med Child Neurol. 1991;33:690-697
12. Odell GB. The distribution and toxicity of bilirubin. E. Mead Johnson address 1969. Pediatrics. 1970;46:16-24
13. Odell GB, Brown RS, Holtzman NA. Dye-sensitized photooxidation of albumin associated with a decreased capacity for protein-binding of bilirubin. Birth Defects Orig Artic Ser. 1970; 6:31-36
14. Hansen TW. Bilirubin brain toxicity. J Perinatol. 2001;21 (suppl 1):S48-S51, discussion S59-S62
15. Grojean S, Koziel V, Vert P, Daval JL. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol. 2000;166:334-341
16. Hoffman DJ, Zanelli SA, Kubin J, Mishra OP, Delivoria- Papadopoulos M. The in vivo effect of bilirubin on the Nmethyl- D-aspartate receptor/ion channel complex in the brains of newborn piglets. Pediatr Res. 1996;40:804-808
17. Ostrow JD, Pascolo L, Shapiro SM, Tiribelli C. New concepts in bilirubin encephalopathy. Eur J Clin Invest. 2003;33:988-997
18. Pojda-Wilczek D, Herba E, Schneiberg B. Visual evoked potentials in children with high blood lead level [in Polish]. Klin Oczna. 2005;107:658-661
19. Stevenson DK, Vreman HJ, Wong RJ. Bilirubin production and the risk of bilirubin neurotoxicity. Semin Perinatol. 2011;35: 121-126
20. Chen YJ, Kang WM. Effects of bilirubin on visual evoked potentials in term infants. Eur J Pediatr. 1995;154:662-666
21. Chen WX, Wong V. Visual evoked potentials in neonatal hyperbilirubinemia. J Child Neurol. 2006;21:58-62
22. Ozmert E, Erdem G, Topçu M, et al. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr. 1996;85:1440-1444
23. Mirabella G, Kjaer PK, Norcia AM, Good WV, Madan A. Visual development in very low birth weight infants. Pediatr Res. 2006;60:435-439
24. Durbin S, Mirabella G, Buncic JR, Westall CA. Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy. Invest Ophthalmol Vis Sci. 2009;50:4011-4016
25. Norcia AM, Tyler CW, Hamer RD. Development of contrast sensitivity in the human infant. Vision Res. 1990;30:1475-1486
26. Norcia AM, Tyler CW. Spatial frequency sweep VEP: visual acuity during the first year of life. Vision Res. 1985;25:1399-1408
27. Skoczenski AM, Norcia AM. Development of VEP Vernier acuity and grating acuity in human infants. Invest Ophthalmol Vis Sci. 1999;40:2411-2417
28. Hou C, Good WV, Norcia AM. Validation study of VEP Vernier acuity in normal-vision and amblyopic adults. Invest Ophthalmol Vis Sci. 2007;48:4070-4078
29. Skoczenski AM, Good WV. Vernier acuity is selectively affected in infants and children with cortical visual impairment. Dev Med Child Neurol. 2004;46:526-532
30. Hou C, Norcia AM, Madan A, Tith S, Agarwal R, Good WV. Visual cortical function in very low birth weight infants without retinal or cerebral pathology. Invest Ophthalmol Vis Sci. 2011;52:9091-9098
31. Norcia AM, Tyler CW, Hamer RD, Wesemann W. Measurement of spatial contrast sensitivity with the swept contrast VEP. Vision Res. 1989;29:627-637
32. Madan A, Norcia AM, Hou C, Pettet MW, Good WV. Effect of Grade I and II intraventricular hemorrhage on visuocortical function in very low birth weight infants. Seeing Perceiving. 2012;25:143-154
33. Sprent P. Applied Non Parametric Statistical Methods. London: Chapman & Hall; 1989
34. Norcia AM, Wesemann W, Manny RE. Electrophysiological correlates of Vernier and relative motion mechanisms in human visual cortex. Vis Neurosci. 1999;16:1123-1131
35. Good WV, Hou C. Sweep visual evoked potential grating acuity thresholds paradoxically improve in low-luminance conditions in children with cortical visual impairment. Invest Ophthalmol Vis Sci. 2006;47:3220-3224
36. Crome L. Morphological nervous changes in survivors of severe jaundice of the newborn. J Neurol Neurosurg Psychiatry. 1955;18:18-23
37. Amato M. Mechanisms of bilirubin toxicity. Eur J Pediatr. 1995;154(9 suppl 4):S54-S59
38. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29:410-421
39. Candy TR, Crowell JA, Banks MS. Optical, receptoral, and retinal constraints on foveal and peripheral vision in the human neonate. Vision Res. 1998;38:3857-3870.